Maravai LifeSciences
Maravai LifeSciences, a leading provider in the life sciences sector, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a pivotal player in the biotechnology industry, focusing on critical areas such as nucleic acid production, protein detection, and cell culture solutions. Maravai's core offerings include high-quality reagents and services that support the development of therapeutics and diagnostics. Their unique approach to custom synthesis and scalable production sets them apart in a competitive market. With a commitment to innovation, Maravai has achieved significant milestones, including strategic acquisitions that enhance their capabilities and market reach. Recognised for their excellence, Maravai LifeSciences continues to drive advancements in life sciences, contributing to the global health landscape.
DitchCarbon Score
How does Maravai LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maravai LifeSciences's score of 28 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Maravai LifeSciences's reported carbon emissions
In 2023, Maravai LifeSciences reported total carbon emissions of approximately 15,490,000 kg CO2e. This figure includes Scope 1 emissions of about 1,549,000 kg CO2e, Scope 2 emissions of approximately 1,993,000 kg CO2e (market-based), and significant Scope 3 emissions totalling around 11,948,000 kg CO2e. The Scope 3 emissions breakdown includes capital goods (about 10,572,000 kg CO2e), business travel (approximately 1,513,000 kg CO2e), and purchased goods and services (around 8,002,000 kg CO2e). In previous years, Maravai's emissions were significantly lower, with 2021 figures showing Scope 1 emissions of about 330,000 kg CO2e and Scope 2 emissions of approximately 1,103,000 kg CO2e (market-based). In 2022, the company reported Scope 1 emissions of around 377,000 kg CO2e and Scope 2 emissions of about 1,309,000 kg CO2e (market-based). Despite the substantial emissions reported, Maravai LifeSciences has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction targets suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 330,000 | 000,000 | 0,000,000 |
| Scope 2 | 1,103,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Maravai LifeSciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
